Lpath, Inc. Sets Investor Update Conference Call for Tuesday, April 6 at 12:00 p.m. ET
SAN DIEGO, CA--(Marketwire - March 31, 2010) - Lpath, Inc. (OTCBB: LPTN), the category leader in bioactive-lipid-targeted therapeutics, will hold a conference call on Tuesday, April 6 at 12:00 p.m. Eastern time to discuss results for the fourth quarter and fiscal year ended December 31, 2009.
Lpath President and CEO Scott Pancoast will host the presentation, followed by a question-and-answer period.
To participate in the call, dial the appropriate number 5-10 minutes prior to the start time, request the Lpath conference call, and provide the conference ID shown below.
Date: Tuesday, April 6, 2010
Time: 12:00 p.m. Eastern time (9:00 a.m. Pacific time)
Dial-In Number: 1-800-895-0231
International: 1-785-424-1054
Conference ID#: 7LPATH
Internet simulcast and replay: http://viavid.net/dce.aspx?sid=000072FF
If you have any difficulty connecting with the conference call, please contact the Liolios Group at 949-574-3860.
A telephone replay of the call will be available from 3:00 p.m. Eastern time on the same day until April 13, 2010 by dialing one of following numbers (no passcode required):
Toll-free replay number: 1-800-388-9074
International replay number: 1-402-220-1117
About Lpath
San Diego-based Lpath, Inc., a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company is currently advancing three drug candidates, two of which -- ASONEP™ for cancer and iSONEP™ for wet age-related macular degeneration (AMD) -- have completed Phase 1 clinical trials. For more information, go to www.Lpath.com.
Lpath, Inc.
Scott R. Pancoast
President & CEO
858-678-0800 x104
Email Contact
Lpath Investor Relations
Liolios Group, Inc. (949) 574-3860
Ron Both: Email Contact
Geoffrey Plank: Email Contact
Email Contact